Member Info for JerseyCrew

Aphrodite. I suggest you read the RNS again. The Scheme vote will likely take place after the sale is complete.

As with most things in life Photographer I suspect it was timing. The SP has been plateaued for a few months so why go deeper in then.... but now as we get closer they know interest will increase and the SP with it.
ATB

There is a lot of emotion being vented for understandable reasons. You can spend time and energy lambasting the BoD and there might be very sound reasons to criticise strategy and timely financial updates in the past but that will not change today,s position. You now need to understand why the Flybe website is still taking bookings today. That is because credit card payments are being accepted and monies released to the company by the credit card companies on the strength of the share purchase agreement entered into by the consortium. If there were a white knight with pockets deep enough to put the credit card company mind at ease and willing to pay more than 1p in uncertain economic times then I would have expected them to be here at the end of last year or before. The economics of this are far more complex that the headline 2.2m offer and investor sentiment and frustration is not going to change that i,m afraid.

SteadyEddie....shareholders can,t vote to accept the offer....only on whether to accept the payment direct to them or not..these are very different issues.

Spring there might well be a case for the BoD to answer but the time that will take to get anywhere near a court will likely be years. Just look at the time that the Lloyds shareholder class action has been running! Unless the BoD were replaced immediately and I have no idea how that could happen legally unless there was clear evidence of fraud and possible police involvement and administrators were appointed, then this deal looks like it will happen. Happy to be corrected if there is a legal solution out there that gives a better ending for all.

The sale to Connect Airways of Flybe's trading subsidiaries is expected to complete by the longstop date of 22 February 2019. This will not require shareholder approval.
Once the sale completes, the Scheme vote will relate purely as to whether to approve an offer of 1p per Flybe Group plc share, payable direct to shareholders by Connect Airways.
I have lifted these 2 sentences. What is not clear or in dispute? Does anyone think the content is able to be challenged under corporate law? People need to read and form their own view.

If you read the RNS wording the vote will purely be on whether to accept the 1p payment direct as in cash payment. There is nothing else going to be asked.

I am not invested here but like many will be watching and learning and I feel for investors who have lost money here many of whom are likely to be hard working flybe staff who would have had no knowledge of the financial crisis facing the company. What I do not understand is why this stock has not been suspended yet if the matter has been taken out of shareholder hands?

Reaction to this RNS will be interesting!
ATB

Fully agree chartbuster. We will see many of these fluctuations in the weeks months and years ahead and some will be a lot larger than this morning's minor temporary retrace. It would highly unusual if it didn't happen!
ATB

And isn,t Haverion just one prospect within Paterson.....when you read the list of projects you realize it is going to take a number of years for the full value of ggp to be ascertained and the potential for a mc in the billions in due course is entirely feasible imo. My timescales are in years however before anyone thinks I am over egging the potential. In the meantime one step at a time.
ATB

flu vaccine not vine - must be close to red wine time in my sub-conscious!

Oct 8th RNS moniman covered 2 new contracts with circa £9M additional revenue which would be largely captured in 2019 - add that to thew cost efficiencies and closure of the R&D site and the net poss pre tax loss of £5.3M for 6 months ending June 18 (I have discounted R&D tax credit as I assume that is diminishing with closure of the office) and I am guessing in the absence of any news (like a flu vine purchase or new contracts!!) then net profit will be in the £1M to £3M range - but that was a fag packet estimate and happy for an accountants view.
ATB

Thanks for explaining Grailor.
Cheers

Of course DL has an agenda but not one that conflicts with GGP. If you look at the presentation issued today on Artemis there is reference to GGP because their Amarda licence boarders onto Haverion, ergo when our next set of drill resu!he are released he wants to point to these to infer similar potential for his company. You can't blame him and he spoke in similar terms when referencing UKOG and other Weald players and I for one have no issues under these circumstances...he knows how to gain publicity and then it is down to investors to do their own research.
Just my take on it.
ATB

Thanks Grailor. We are certainly of the same page....my regulatory approval (potential) comment was a nod to the FDA who hold the golden keye. My question was about the data gathering....i.e. number of case / trial patients...do the comments mean that potentially they have enough data to satisfy phase III when they reference end points? I value your industry experience and welcome your take on this.
ATB

A statistically significant additional endpoint has been achieved (p=0.006) from further data analysed by the NIAID from FLU-v 004, which confirmed the result for the primary endpoint and has the potential to become the primary regulatory endpoint for Phase III
Question for experts familiar with the test phasing. Does this comment from the last RNS mean that potentially with the backing of regulatory approval that Phase III data gathering might already be complete? I know that regulatory bodies can take an age but if I have understood correctly surely that has to be a huge selling point at this stage? Moving one step further in my musings this morning, I presume each tick for phasing increases the bargaining strength with a major and wonder therefore what the optimum time is within the development lifecycle to make deal to maximize the return.
Thoughts or opinion on anything I have raised?
ATB folks.

Like him or loathe him one thing you can not ignore is that he creates exposure and I believe that is a good. As to what his personal agenda here is ....time will tell.
ATB

I'll drink to that SmokeyRose.
ATB

Apologies. SmokeyRose.